ASC therapies & procedures
Medtronic Cardiovascular offers a breadth of technologies at the therapeutic, procedural, and system level across cardiovascular diseases. Additionally, we offer a breadth of services to help address unique challenges in your clinical practice, and to support increased capacity and the patient experience.
Below you will find more information on:
Percutaneous coronary intervention (PCI) is a versatile procedure leveraging various tools — including catheters, wires, balloons, and stents. Every PCI is different, so we offer ambulatory surgery centers a robust portfolio of products with various sizes to customize your outpatient PCI procedures, as well as educational resources to help enhance your expertise.
Address patients with coronary artery disease in your ASC with our portfolio, including but not limited to:
Resolute Onyx™ DES offers the deliverability,1 conformability,2 and visibility3 needed for PCI. Additionally, Resolute Onyx DES is indicated for more complex PCI techniques and patients, including non-left main bifurcation using the provisional stenting technique, chronic total occlusion (CTO), and high bleeding risk patients with one-month DAPT labeling.4
PCI requires semicompliant and noncompliant balloon options to address specific lesion characteristics.
Leverage a complete range of coronary and peripheral curves with our guide catheters.
We're transforming your ability to diagnose and treat even the most difficult-to-detect arrhythmias with a variety of insertable cardiac monitors (ICMs). To learn more about our product portfolio, visit the site below.
Atrial fibrillation, also known as AF, is an irregular heart rhythm that affects the upper chambers (atria) of the heart. In AF, the atria quiver instead of beating normally. AF can also lead to rapid heart rhythm, where the heart can beat as much as 300 times a minute or more in the atria, and up to 150 times a minute or more in the lower chambers (ventricles).
Catheter ablation for AF is a technique employed to control heart rhythms that are caused by abnormal electrical signals traveling from the pulmonary veins to the atria. It’s a minimally invasive procedure that can be used when medication fails to control AF. During the procedure, catheters are used to terminate (ablate) these abnormal electrical signals and stop them from spreading and continuing to cause AF.
The catheters have electrodes that can sense intracardiac electrical signals when connected to the electrophysiology lab system. The resulting electrograms are used to determine the optimal placement of the ablation catheter. The ablation catheter delivers energy to create a discrete lesion of myocardial scar tissue which terminates the abnormal electrical signals.
Medtronic offers ablation catheters that use cryothermal energy to create lesions via the rapid removal of heat from cardiac cells.
With its proven safety and efficacy profile, the Arctic Front™ family of cryoballoons are approved in the U.S. to treat drug refractory, recurrent, symptomatic, paroxysmal, and persistent atrial fibrillation (episode duration less than 6 months).5 The cryoballoon, paired with the FlexCath Advance™ steerable sheath and Achieve™ family of mapping catheters is used for AF physiological intervention that delivers a consistent, simple pulmonary vein isolation (PVI) ablation procedure with safe cryo technology. Over 650,000 patients worldwide have been treated with the cryoballoon.6
Peripheral arterial disease (PAD), which can also be referred to as peripheral vascular disease (PVD), is the narrowing or blockage of arteries in various critical regions of the body. When the disease presents in the lower limbs, blood flow is reduced and can cause damage to tissue in your lower limbs. PAD is a progressive disease ranging from mild to moderate claudication to critical limb ischemia (CLI) which can lead to amputation.
PAD is a progressive disease that can limit patients’ mobility, quality of life, and if not addressed can lead to amputation. Endovascular treatment options including balloon angioplasty, atherectomy, and stenting are minimally invasive therapies to treat blocked arteries without the need for open surgery.
Medtronic offers a suite of endovascular technology solutions that enable effective treatment of claudication including the HawkOne™ directional atherectomy system, the IN.PACT™ Admiral™ drug-coated balloon, and the Chocolate™* PTA balloon catheter.
Critical limb ischemia (CLI) is a growing health concern that significantly impacts patient quality of life and ability to function. As the population ages, the disease will become more prevalent.
Medtronic’s products can help you address this debilitating disease by relieving pain, improving function, and restoring hope for CLI patients.
Medtronic’s portfolio to treat CLI disease includes technologies to access, cross, and treat multilevel disease with confidence.
The IN.PACT AV drug-coated balloon for AV fistula maintenance can slow the progression of fistula stenosis. A functioning fistula can eliminate the need for catheter-based dialysis, decreasing risk of infection and all-cause mortality.7
The IN.PACT AV DCB may enable dramatically fewer AV fistula reinterventions, which could keep patients out of the hospital longer for AV fistula maintenance.7 It can make a real impact — clinically, financially,8 and emotionally.
Combining proven Lean Sigma methodologies with extensive change management expertise, we work directly with your healthcare administration leaders and care teams to find solutions to the unique challenges at your site impacting operational efficiency, staff satisfaction and performance, and the patient experience.
We have successfully led more than 120 hospital and clinic engagements in a wide range of cardiovascular settings, including cardiac catheterization (cath) and electrophysiology (EP) labs, hybrid operating room (OR) settings, and outpatient clinics.
Healthcare optimization engagements are always customized to meet your specific goals. Whether it’s building a new program or refining an existing one, we’re here to help you expand patient access, improve the quality and cost-effectiveness of healthcare delivery, and ensure sustainable success.
The next generation McGRATH™ MAC video laryngoscope is an enhanced, more robust device, designed to be durable and used throughout the day. Add McGRATH™ to your ASC to make your first attempt your best.
Have a representative contact you for more information about ASC therapies and procedures.
Medical necessity will dictate site of service for each individual patient. Physicians should confirm inpatient or outpatient admission criteria before selecting site of service.
™*Third-party brands are trademarks of their respective owners.
Based on bench test data on file at Medtronic (D00339634). May not be indicative of clinical performance.
Third-party modeling and analysis on file at Medtronic (Mortier Conformability Report). May not be indicative of clinical performance. Evaluated the following stent platforms: Resolute Onyx DES, SYNERGY DES, and XIENCE Alpine™* DES (Multi-Link 8™* BMS platform).
Based on bench test data on file at Medtronic (University of Budapest Visibility Testing). May not be indicative of clinical performance. N = 3 of each DES tested (3.0 mm) Onyx Frontier DES, Orsiro®* DES, XIENCE Alpine DES, and SYNERGY DES.
Resolute Onyx DES instructions for use.
Packer DL, Kowal RC, Wheelan KR, et al. Cryoballoon Ablation of Pulmonary Veins for Paroxysmal Atrial Fibrillation: First Results of the North American Arctic Front (STOP AF) Pivotal Trial. J Am Coll Cardiol. April 23, 2013; 61(16):1713–1723.
Medtronic data on file.
Lookstein RA, Haruguchi H, Ouriel K, et al. Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas. N Engl J Med. August 20, 2020;383(8):733–742.
Thamer M, Lee TC, Wasse H, et al. Medicare Costs Associated With Arteriovenous Fistulas Among US Hemodialysis Patients. Am J Kidney Dis. July 2018;72(1):10–18.